Cargando…
Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics
The blood-brain barrier (BBB) is an essential component in regulating and maintaining the homeostatic microenvironment of the central nervous system (CNS). During the occurrence and development of glioblastoma (GBM), BBB is pathologically destroyed with a marked increase in permeability. Due to the...
Autores principales: | WANG, KAI, ZHANG, FENGTIAN, WEN, CHANGLONG, HUANG, ZHIHUA, HU, ZHIHAO, ZHANG, YUWEN, HU, FUQIANG, WEN, LIJUAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208024/ https://www.ncbi.nlm.nih.gov/pubmed/37305160 http://dx.doi.org/10.32604/or.2022.025696 |
Ejemplares similares
-
Effect of axitinib regulating the pathological blood–brain barrier functional recovery for glioblastoma therapeutics
por: Zhang, Fengtian, et al.
Publicado: (2021) -
Intracranial delivery of synthetic mRNA to suppress glioblastoma
por: Peng, Hao, et al.
Publicado: (2021) -
Sequential delivery of therapeutic agents using a rationally designed disulfide-linked glycolipid-like nanocarrier
por: Hu, Yingwen, et al.
Publicado: (2016) -
Biological Characterization and Therapeutics for Subscalp Recurrent in Intracranial Glioblastoma
por: Zhang, Junwen, et al.
Publicado: (2020) -
Enhancing Drug Delivery for Overcoming Angiogenesis and Improving the Phototherapy Efficacy of Glioblastoma by ICG-Loaded Glycolipid-Like Micelles
por: Liu, Yupeng, et al.
Publicado: (2020)